Kidney Function Tests Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Urine Tests, Blood Tests), By Component (Dipsticks, Reagents, Kits & Assays, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region

Abstract
Global kidney function tests market was valued over USD 862 million in 2022 and is forecast to grow at a CAGR of 9.71% through 2028. The growth of the global market for kidney function tests is anticipated to be supported by an increase in awareness of diagnostic techniques for kidney function. The growing global burden of chronic kidney disease is attributed in huge share to diabetes and high blood pressure. In the upcoming years, rising diabetes rates will have an effect on market expansion. The International Diabetes Atlas' tenth edition estimates that 537 million adults (20-79 years old), or one in ten people, had diabetes in 2021. It is anticipated that this number will increase to 643 million by 2030 and 783 million by 2045. Kidneys are among the most vital organs of the human body. Kidneys acts as blood filters, reabsorbing the essential elements and removing the water-soluble waste products from the blood. Hence, they require constant regeneration of dead nephrons and proper blood circulation to maintain healthy cell growth, otherwise they become vulnerable to cancerous tumors and metastasis. The functional damage of the kidney is common across the world and its incidents are increasing at a rapid pace. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet due to a buildup of fluids in the body.

Rising Prevalence of Kidney Disorders and Diseases
The growing occurrence of several kidney disorders such as acquired cystic kidney disease, amyloidosis & kidney disease, diabetes insipidus, ectopic kidney, glomerular diseases, anti-GBM (Goodpasture's) disease, IgA nephropathy, among others have drastically increased the number of patients which requires accurate diagnosis and proper treatment. This, in turn, is expected to drive the growth of the global kidney function tests market. Furthermore, acute kidney injury (AKI), also known as acute renal failure or acute kidney injury, is very common in patients who are in hospitals. Acute kidney injury (AKI) affects more than 13 million people and results in 1.7 million deaths every year across the globe. Owing to the rising incidences of kidney diseases and disorders, the demand for early diagnosis and treatments is expected to surge, which bolsters the growth of the market. For instance, according to the Centers for Disease Control and Prevention (CDC), 40% of people with rigorously reduced kidney function are not aware of having chronic kidney disease (CKD).

Technological Advancements
Rising adoption of advanced technology concerning diagnosis and treatment is expected to bolster the growth of the market. These continuous developments and innovations are providing better treatments to patients. The latest trends in technology are using computer-based intelligent decision support systems (DSS) and expert systems, which are used in dialysis and are based on genetic algorithms and artificial neural networks (ANN). Also, the increase in interest in the internet of things (IoT), deep learning, an expanded and complex version of shallow ANN, is being used in the medical field. These advancements help in image diagnosis, alerting systems, and diagnostic assistance.


Increase in the Prevalence of Diabetes and Hypertension
The growing occurrences of underlying conditions such as diabetes and hypertension among the masses have significantly increased the demand for getting diagnoses and treatments done for these chronic diseases. This, in turn, is expected to positively influence the growth of the global kidney function tests market. According to the Centers for Disease Control and Prevention (CDC), in 2019, there are approximately 37.3 million people who have diabetes, accounting for 11.3% of the US population. Out of these, 28.7 million people are diagnosed, and 8.5 million people are undiagnosed. Rising geriatric population is more prone to kidney diseases and kidney failures as aging increases the risk of chronic diseases such as diabetes and hypertension. The increase in the number of elders suffering from diabetes and hypertension is surging the demand for kidney function tests, as kidney disorders and kidney failures are caused by these chronic diseases. Therefore, owing to the rising prevalence of diabetes and hypertension, there is a surge in the number of cases of Chronic Kidney Disease (CKD) and Acute Kidney Injury (AKI), which in turn, is facilitating the growth of the market.
Recent Developments
•In 2019, Fresenius Medical Care received breakthrough device designation by the U.S. FDA for its most recent hemodialysis machine, whose objective is to stop blood clotting without using any medication
•Similarly, in 2019, CareDx announced the new model built for kidney transplants. It has included Predicted artificial intelligence (AI) for individuals who are suffering from chronic kidney diseases (CKD).
•Recently, in 2022, bioMérieux received United States Food and Drug Administration (US FDA) authorization for the innovative VIDAS NEPHROCHECK assay to detect kidney stress in individuals who are at risk of acute kidney injury (AKI).

Market Segmentation
Global kidney function tests market segmentation is based on type, component, end user, regional distribution, and competitional landscape. Based on type, the market is divided into urine tests, blood tests and others. Urine tests are further subcategorized into Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests. Blood tests are further categorized into Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests. Based on component, the market is categorized into Dipsticks, Reagents, Kits & Assays, and Others. Based on end user, the market is further bifurcated into Hospitals & Clinics, Diagnostic Laboratories, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to the rising cases of renal disorders.
Market Players
Baxter International Inc., Abbott Laboratories, Inc., Sysmex Corporation., F. Hoffmann-La Roche Ltd., Danaher Corporation., URIT Medical Electronic Co. Ltd., Nova Biomedical Corporation., Laboratory Corporation of America Holdings., Siemens Healthineers., ARKRAY Inc., IDEXX Laboratories, Inc., Fresenius SE & Co. KGaA., Cook Group., ACON Laboratories, Inc, and Randox Laboratories Ltd. are some of the leading companies operating in the market.


Report Scope:
In this report, global kidney function tests market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
•Kidney Function Tests Market, By Type:
oUrine Tests
Urine Protein Tests
Creatinine Clearance Tests
Microalbumin Tests
oBlood Tests
Serum Creatinine Tests
Glomerular Filtration Rate Tests
Blood Urea Nitrogen Tests
oOthers
•Kidney Function Tests Market, By Component:
oDipsticks
oReagents
oKits & Assays
oOthers
• Kidney Function Tests Market, By End User:
oHospitals & Clinics
oDiagnostic Laboratories
oOthers
•Kidney Function Tests Market, By Region:
oNorth America
United States
Canada
Mexico
oEurope
France
Germany
United Kingdom
Netherlands
Sweden
Italy
Spain
oAsia-Pacific
China
Japan
Singapore
India
South Korea
Australia
oSouth America
Brazil
Argentina
Colombia
oMiddle East & Africa
UAE
Saudi Arabia
South Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Kidney Function Tests market

Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
•Detailed analysis and profiling of additional market players (up to five).

Content
Table of Contents

1.Product Overview
2.Research Methodology
3.Executive Summary
4.Voice of Customer
4.1.Prevalence of Kidney Disorders, By Gender
4.2.Prevalence of Kidney Disorders, By Age Group
4.3.Patient's Awareness of Suffering From Chronic Kidney Disorder
4.4.Commonly Observed Kidney Disorders
4.5.Commonly Used Tests for Performing Kidney Function Tests
5.Global Kidney Function Tests Market Outlook
5.1.Market Size & Forecast
5.1.1.By Value
5.2.Market Share & Forecast
5.2.1.By Type (Urine Tests and Blood Tests)
5.2.1.1.By Urine Tests (Urine Protein Tests, Creatinine Clearance Tests, Microalbumin Tests)
5.2.1.2.By Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, Blood Urea Nitrogen Tests)
5.2.2.By Component (Dipsticks, Reagents, Kits & Assays, Others)
5.2.3.By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.4.By Region
5.3.Market Map
5.3.1.By Type
5.3.2.By Component
5.3.3.By End User
5.3.4.By Region
6.North America Kidney Function Tests Market Outlook
6.1.Market Size & Forecast
6.1.1.By Value
6.2.Market Share & Forecast
6.2.1.By Type
6.2.2.By Component
6.2.3.By End User
6.3.North America: Country Analysis
6.3.1.United States Kidney Function Tests Market Outlook
6.3.1.1.Market Size & Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share & Forecast
6.3.1.2.1.By Type
6.3.1.2.2.By Component
6.3.1.2.3.By End User
6.3.2.Canada Kidney Function Tests Market Outlook
6.3.2.1.Market Size & Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share & Forecast
6.3.2.2.1.By Type
6.3.2.2.2.By Component
6.3.2.2.3.By End User
6.3.3.Mexico Kidney Function Tests Market Outlook
6.3.3.1.Market Size & Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share & Forecast
6.3.3.2.1.By Type
6.3.3.2.2.By Component
6.3.3.2.3.By End User
7.Europe Kidney Function Tests Market Outlook
7.1.Market Size & Forecast
7.1.1.By Value
7.2.Market Share & Forecast
7.2.1.By Type
7.2.2.By Component
7.2.3.By End User
7.2.4.By Region
7.3.Europe: Country Analysis
7.3.1.France Kidney Function Tests Market Outlook
7.3.1.1.Market Size & Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share & Forecast
7.3.1.2.1.By Type
7.3.1.2.2.By Component
7.3.1.2.3.By End User
7.3.2.Germany Kidney Function Tests Market Outlook
7.3.2.1.Market Size & Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share & Forecast
7.3.2.2.1.By Type
7.3.2.2.2.By Component
7.3.2.2.3.By End User
7.3.3.United Kingdom Kidney Function Tests Market Outlook
7.3.3.1.Market Size & Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share & Forecast
7.3.3.2.1.By Type
7.3.3.2.2.By Component
7.3.3.2.3.By End User
7.3.4.Netherlands Kidney Function Tests Market Outlook
7.3.4.1.Market Size & Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share & Forecast
7.3.4.2.1.By Type
7.3.4.2.2.By Component
7.3.4.2.3.By End User
7.3.5.Sweden Kidney Function Tests Market Outlook
7.3.5.1.Market Size & Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share & Forecast
7.3.5.2.1.By Type
7.3.5.2.2.By Component
7.3.5.2.3.By End User
7.3.6.Italy Kidney Function Tests Market Outlook
7.3.6.1.Market Size & Forecast
7.3.6.1.1.By Value
7.3.6.2.Market Share & Forecast
7.3.6.2.1.By Type
7.3.6.2.2.By Component
7.3.6.2.3.By End User
7.3.7.Spain Kidney Function Tests Market Outlook
7.3.7.1.Market Size & Forecast
7.3.7.1.1.By Value
7.3.7.2.Market Share & Forecast
7.3.7.2.1.By Type
7.3.7.2.2.By Component
7.3.7.2.3.By End User
8.Asia-Pacific Kidney Function Tests Market Outlook
8.1.Market Size & Forecast
8.1.1.By Value
8.2.Market Share & Forecast
8.2.1.By Type
8.2.2.By Component
8.2.3.By End User
8.2.4.By Region
8.3.Asia-Pacific: Country Analysis
8.3.1.China Kidney Function Tests Market Outlook
8.3.1.1.Market Size & Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share & Forecast
8.3.1.2.1.By Type
8.3.1.2.2.By Component
8.3.1.2.3.By End User
8.3.2.Japan Kidney Function Tests Market Outlook
8.3.2.1.Market Size & Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share & Forecast
8.3.2.2.1.By Type
8.3.2.2.2.By Component
8.3.2.2.3.By End User
8.3.3.Singapore Kidney Function Tests Market Outlook
8.3.3.1.Market Size & Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share & Forecast
8.3.3.2.1.By Type
8.3.3.2.2.By Component
8.3.3.2.3.By End User
8.3.4.India Kidney Function Tests Market Outlook
8.3.4.1.Market Size & Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share & Forecast
8.3.4.2.1.By Type
8.3.4.2.2.By Component
8.3.4.2.3.By End User
8.3.5.South Korea Farming Market Outlook
8.3.5.1.Market Size & Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share & Forecast
8.3.5.2.1.By Type
8.3.5.2.2.By Component
8.3.5.2.3.By End User
8.3.6.Australia Farming Market Outlook
8.3.6.1.Market Size & Forecast
8.3.6.1.1.By Value
8.3.6.2.Market Share & Forecast
8.3.6.2.1.By Type
8.3.6.2.2.By Component
8.3.6.2.3.By End User
9.South America Kidney Function Tests Market Outlook
9.1.Market Size & Forecast
9.1.1.By Value
9.2.Market Share & Forecast
9.2.1.By Type
9.2.2.By Component
9.2.3.By End User
9.2.4.By Region
9.3.South America: Country Analysis
9.3.1.Brazil Kidney Function Tests Market Outlook
9.3.1.1.Market Size & Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share & Forecast
9.3.1.2.1.By Type
9.3.1.2.2.By Component
9.3.1.2.3.By End User
9.3.2.Argentina Kidney Function Tests Market Outlook
9.3.2.1.Market Size & Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share & Forecast
9.3.2.2.1.By Type
9.3.2.2.2.By Component
9.3.2.2.3.By End User
9.3.3.Colombia Kidney Function Tests Market Outlook
9.3.3.1.Market Size & Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share & Forecast
9.3.3.2.1.By Type
9.3.3.2.2.By Component
9.3.3.2.3.By End User
10.Middle East and Africa Kidney Function Tests Market Outlook
10.1.Market Size & Forecast
10.1.1.By Value
10.2.Market Share & Forecast
10.2.1.By Type
10.2.2.By Component
10.2.3.By End User
10.2.4.By Region
10.3.MEA: Country Analysis
10.3.1.UAE Kidney Function Tests Market Outlook
10.3.1.1.Market Size & Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share & Forecast
10.3.1.2.1.By Type
10.3.1.2.2.By Component
10.3.1.2.3.By End User
10.3.2.Saudi Arabia Kidney Function Tests Market Outlook
10.3.2.1.Market Size & Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share & Forecast
10.3.2.2.1.By Type
10.3.2.2.2.By Component
10.3.2.2.3.By End User
10.3.3.South Africa Kidney Function Tests Market Outlook
10.3.3.1.Market Size & Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share & Forecast
10.3.3.2.1.By Type
10.3.3.2.2.By Components
10.3.3.2.3.By End User
11.Market Dynamics
11.1.Drivers
11.1.1.Rising Prevalence of Kidney Disorders and Diseases
11.1.2.Technological Advancements
11.1.3.Increase in the Prevalence of Diabetes and Hypertension
11.2.Challenges
11.2.1.Stringent Regulatory Approvals
11.2.2.Lack of Awareness
11.2.3.False Positive Report
12.Market Trends & Developments
12.1.At-Home Diagnostic Test for Kidney Diseases
12.2.Rise in New Kidney Tests
12.3.Increasing Collaborations
13.Competitive Landscape
13.1.Business Overview
13.2.Product Offerings
13.3.Recent Developments
13.4.Financials (As Reported)
13.5.Key Personnel
13.6.SWOT Analysis
13.6.1.Baxter International Inc
13.6.2.Abbott Laboratories, Inc.
13.6.3.Sysmex Corporation
13.6.4.F. Hoffmann-La Roche Ltd
13.6.5.Danaher Corporation
13.6.6.URIT Medical Electronic Co. Ltd
13.6.7.Nova Biomedical Corporation
13.6.8.Laboratory Corporation of America Holdings
13.6.9.Siemens Healthineers
13.6.10.ARKRAY Inc.
13.6.11.IDEXX Laboratories, Inc
13.6.12.Fresenius SE & Co. KGaA
13.6.13.Cook Group
13.6.14.ACON Laboratories, Inc.
13.6.15.Randox Laboratories Ltd.
14.Strategic Recommendations